Table 1 Clinicopathological parameters of 98 patients with extrahepatic bile duct cancer
From: Prognostic value of functional SMAD4 localization in extrahepatic bile duct cancer
Variables | n (%) | |
|---|---|---|
All | 98 | |
Race | Asian | 98 (100.0%) |
Others | 0 (0.0%) | |
Gender | Men | 69 (70.5%) |
Women | 29 (29.6%) | |
Age | 68.2 ± 9.0a | |
Operative procedure | Hepatectomy | 44 (44.9%) |
Pancreaticoduodenectomy | 54 (55.1%) | |
Location | Perihilar | 44 (44.9%) |
Distal | 54 (55.1%) | |
Histological type | Well or moderately | 80 (81.6%) |
Poorly | 18 (18.4%) | |
UICC8th_pT | 1 or 2 | 45 (45.9%) |
3 or 4 | 53 (54.1%) | |
UICC8th_pN | 0 | 61 (62.2%) |
1 or 2 | 37 (37.8%) | |
Microinvasion into lymphatic system | Absent | 47 (48.0%) |
Present | 51 (52.0%) | |
Microinvasion into venous system | Absent | 69 (70.4%) |
Present | 29 (29.6%) | |
Microinvasion into nervous system | Absent | 27 (27.6%) |
Present | 71 (72.4%) | |
Invasion into liver | Absent | 72 (73.5%) |
Present | 26 (26.5%) | |
Invasion into pancreas | Absent | 61 (62.2%) |
Present | 37 (37.8%) | |
Invasion into portal vein | Absent | 87 (88.8%) |
Present | 11 (11.2%) | |
Invasion into artery | Absent | 89 (91.8%) |
Present | 8 (8.2%) | |
Residual tumor | R0 | 78 (79.6%) |
R1 | 20 (20.4%) | |
Adjuvant therapy | Done | 46 (46.9%) |
Not done | 52 (53.1%) |